SEC Form 4 · accession 0001128732-16-000016
Sunshine Biopharma Inc. · SBFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Abderrazzak Merzouki
Officer — Chief Operating Officer · Director
Period of report
Apr 22, 2016
Accepted (ET)
Apr 25, 2016 · 7:30 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001402328
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 22, 2016 | A | 12,000,000 | $0.007 | A | 13,467,000 | D |
Table II — derivative securities
No Table II lines on this filing.